CAS: 226929-39-1 - LB42708
![4-[[1-[[1-[(4-Bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]carbo…](https://static.cymitquimica.com/products/IN/thumb/DA0039B1.jpg)
4-[[1-[[1-[(4-Bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]carbonyl]morpholine
CAS:226929-39-1
Formula:
C30H27BrN4O2
Purity:
97%
Color and Shape:
Solid
Molecular weight:
555.4650
Ref: IN-DA0039B1
| 5mg | 468.00 € | ||
| 25mg | 474.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
LB 42708
Controlled ProductCAS:226929-39-1
Applications LB 42708 is a selective nonpeptidic Farnesyltransferase (FTase) inhibitor.LB42708 suppresses tumor growth and tumor …
Formula:
C30H27BrN4O2
Color and Shape:
Neat
Molecular weight:
555.46
Ref: TR-L178790
| 5mg | 160.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
LB42708
CAS:226929-39-1
LB42708 is an orally active farnesyltransferase (FTase) inhibitor (IC50: 0.8/1.2/2.0 nM toward H/N/K-ras).
Formula:
C30H27BrN4O2
Purity:
97.83%
Color and Shape:
Solid
Molecular weight:
555.47
Ref: TM-T2678
| 1mg | 49.00 € | ||
| 2mg | 68.00 € | ||
| 5mg | 100.00 € | ||
| 10mg | 148.00 € | ||
| 25mg | 277.00 € | ||
| 50mg | 410.00 € | ||
| 100mg | 575.00 € | ||
| 1mL*10mM (DMSO) | 132.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
(1-((1-(4-Bromobenzyl)-1H-imidazol-5-yl)methyl)-4-(naphthalen-1-yl)-1H-pyrrol-3-yl)(morpholino)methanone
CAS:226929-39-1
This drug is a prodrug that is metabolized by hydrolysis to form the active metabolite, …
Formula:
C30H27BrN4O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
555.47 g/mol
Ref: 3D-BJA92939
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
